Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Adrenal scintiscanning with NP-59: a new radioiodinated cholesterol agent. [NP-59 = (6. beta. -/sup 131/I)iodomethyl-19-norcholest-5(10)-en-3. beta. -ol]

Journal Article · · Mayo Clin., Proc.; (United States)
OSTI ID:7031443
Adrenal imaging in the past has been limited in its clinical application by the long interval between administration of dose and visualization of adrenal glands. We review our experience with the use of a newer labeling agent, NP-59, in 29 patients with various adrenal disorders and in 4 normal subjects. With this agent, identification of adrenal lesions is possible with a high degree of accuracy, and diagnostic information is usually available within 48 hrs. NP-59 is particularly useful in evaluating primary aldosteronism and selected cases of Cushing's syndrome.
Research Organization:
Mayo Graduate School of Medicine, Rochester, MI
OSTI ID:
7031443
Journal Information:
Mayo Clin., Proc.; (United States), Journal Name: Mayo Clin., Proc.; (United States) Vol. 54:5; ISSN MACPA
Country of Publication:
United States
Language:
English